Biomarkers in COPD: time for a deep breath
- 1 August 2007
- Vol. 62 (8) , 657-660
- https://doi.org/10.1136/thx.2007.084228
Abstract
Biomarkers need to fulfil several distinct requirements before they can be considered a valid indicator of chronic diseases such as COPDKeywords
This publication has 22 references indexed in Scilit:
- Systemic inflammation and decline in lung function in a general population: a prospective studyThorax, 2007
- Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Raloxifene Modulates Interleukin-6 and Tumor Necrosis Factor-α Synthesisin Vivo: Results from a Pilot Clinical StudyJournal of Clinical Endocrinology & Metabolism, 2004
- Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in WomenDiabetes Care, 2004
- Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the MouseAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Multifaceted roles of TNF‐α in myoblast destruction: A multitude of signal transduction pathwaysJournal of Cellular Physiology, 2003
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Neutrophils and Protease/Antiprotease ImbalanceAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor αThe FASEB Journal, 1998
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin ResistanceScience, 1996